Pathology of oligodendroglia and myelinated fibers of the hippocampus in schizophrenia (an ultrastructural and morphometric study)

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 108, Issue 8, 2008, Pages 52-60

  Kolomeets, N S ^a   Uranova, N A ^a  

^a NONE

Author keywords

Glia; Hippocampus; Myelinated fibers; Neuropathology; Oligodendrocytes; Schizophrenia

Indexed keywords

EID: 52049103612     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Russian source
2. Russian source
3. Russian source
4. Russian source
5. Andreasen N. C., Olsen S. Negative vs. positive schizophrenia: definition and validation. Arch Gen Psychiat 1982; 39: 789-794.
6. Arnold S.E., Franz B.R., Gur R. C. et al. Smaller neuron size in schizophreniain hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiat 1995; 152: 738-748.
7. Barres B.A., Martin C., Raff M.C. Axonal control of oligodendrocyte development. J Cell Biol 1999; 147: 1123-1128.
8. Benes F.M., Turtle M., Khan Y. et al. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiat 1994; 51: 477-484.
9. Bsibsi M., Persoon-Deen C., Verwer R. W. et al. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 2006; 53; 688-695.
10. Cassell M.D., Brown M.W. The distribution of Timm's stain in the nonsulfide-perfused human hippocampal formation. J Comp Neurol 1984; 222: 461-471.
11. Chambers J.S., Perrone-Bizzozero N.I. Altered myelination of the hippocampal formation in subjects with schizophrenia and bi polar disorder. Neurochem Res 2004; 29: 2293-2302.
12. Dai X., Lercher L.D., Patricia M. et al. The trophic role of oligodendrocytes in the basal forebrain. J Neurosci 2003; 23: 5846-5853.
13. Davies D.C., Wardell A.M., Woolsey R. et al. Enlargement of the fornix in early-onset schizophrenia: a quantitative MRI study. Neurosci Let 2001; 301: 163-166.
14. Davis J.M. Dose equivalent of the antipsychotic drugs. J Psychiat Res 1974; 11: 65-69.
15. Davis K.L., Stewart D.G., Friedman J.I. et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiat 2003; 60: 443-456.
16. Dracheva S., Davis K.L., Chin B. et al. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortexand hippocampus in elderly schizophrenia patients. Neurobiol Dis 2006; 21: 531-540.
17. Esiri M.M., Pearson R.C.A. Perspectives from other diseases and lesions. In: The neuropathology of schizophrenia. Progress and interpretation. P.J. Harrison, G.W. Roberts (eds). Oxford: Oxford Press 2000; 257-276.
18. Fields R. D. Myelination: An overlooked mechanism of synaptic plasticity? Neuroscientist 2005; 11: 528-531.
19. Gallo V., Ghiani C.A. Glutamate receptors in glia: new cells, new inputs and new functions. Trends Pharmacol Sci 2000; 21: 252-258.
20. Ganguli R., Brar J.S., Solomon W. et al Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production. Psychiat Res 1992; 44: 113-123.
21. Ganguli R., Brar J.S., Chengappa K.R. et al. Mitogen-stimulated interleukin 2 production in never-medicated first episode schizophrenics-the influence of age of onset and negative symptoms. Arch Gen Psychiat 1995; 52: 668-672.
22. Griffiths I.R., Klugmann M., Anderson T. et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 1998; 280: 1610-1613.
23. Ishibashi T., Dakin K.A., Stevens B. et al Astrocytes promote myelination in response to electrical impulses. Neuron 2006; 49: 823-832.
24. Harrison P.J., Eastwood S.L. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 2001; 11: 508-519.
25. Haydon P.G., Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 2006; 86: 1009-1031.
26. Ho B.-C., Milev P., O'Leary D.S. et al. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiat 2006; 63: 731-740.
27. Hof P.R., Haroutunian V., Copland C. et al. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res 2002; 27: 1193-1200.
28. Katsel P., Davis K.L., Haroutunian V. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res 2005; 79: 157-173.
29. Kubicki M., Park H., Westin C.F. et al. DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage 2005; 26: 1109-1118.
30. Kuroki N., Kubicki M., Nestor P.G. et al. Fornix integrity and hippocampal volume in male schizophrenic patients. Biol Psychiat 2006; 60: 22-31.
31. Law A.J., Weickert C.S., Hyde T.M. et al Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. Am J Psychiat 2004; 161: 1848-1855.
32. Law A.J.,Lipska B.K., Weickert C.S. et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci USA 2006; 103: 6747-6752.
33. Lim C., Mufson E.J., Kordower J.H. et al. Connections of the hippocampal formation in humans: II. The endfolial fiber pathway. J Comp Neurol 1997; 385: 352-371.
34. Markham J., Greenough W.T. Experience-driven brain plasticity: beyond the synapse. Neuron Glia Biol 2004; 1: 351-363.
35. Miyakawa T., Sumiyoshi S., Deshimaru M.H. et al. Electron microscopic study on schizophrenia. Mechanism of pathological changes. Acta Neuropathologica 1972; 20: 67-77.
36. Nelson M.D., Saykin A.J., Flashman L.A. et al. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging. A meta-analytic study. Arch Gen Psychiat 1998; 55: 433-440.
37. Olypher A.V., Klement D., Fenton A.A. Cognitive disorganization in hi ppocampus: a physiological model of the disorganization in psychosis. J Neurosci 2006; 26: 158-168.
38. Qi Y., Dal Canto M.C. Effect of Theiler's murine encephalomyelitis virus and cytokines on cultured oligodendrocytes and astrocytes. J Neurosci Res 1996; 45: 364-374.
39. Peters A., Palay S., Webster H. de F. The Fine Structure of the Nervous System: the Neuron and the Supporting Cells. Oxford, UK: Oxford Univ Press 1991.
40. Peters A., Sethares C. Aging and the myelinated fibersin prefrontal cortex and corpus callosum of the monkey. J Compar Neurol 2002; 442: 277-291.
41. Sánchez-Gómez M. V., Alberdi E., Ibarretxe G. et al Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J Neurosci 2003; 23: 9519-9528.
42. Schmithorst V.J., Wilke M., Dardinski B.J. et al. Cognitive functions correlate with white matter architecture in normal pediatric population: a diffusion tensor MRI study. Hum Brain Mapp 2005; 26: 139-147.
43. Senitz D., Winkelmann E. Morphology of the orbitofrontal cortex in persons schizophrenic psychotics. A Golgi and electron microscopy study. Psychiat Neurol Med Psychol 1981; 33: 1-9.
44. Spiegel I., Peles E. A new player in CNS myelination. Neuron 2006; 49: 777-778.
45. Tekkok S.B., Goldberg M.P. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 2001; 21: 4237-4248.
46. Uranova N.A., Zimina I.S., Vikhreva O. V. et al. Morphometric study of ultrastructural alterations of myelinated fibers in post-mortem schizophrenic brains. Schizophr Res 1999; 36: 85.
47. Uranova N., Orlovskaya D., Vikhreva O. et al. Electron microscopic study of oligodendroglia in severe mental illness. Brain Res. Bull 2001; 5: 597-610.
48. Uranova N.A., Vostrikov V.M., Orlovskaya D.D. et al. Oligodendroglial density in the prefrontal cortex area 9 in schizophrenia and mood disorders: A study of brain collection from the Stanley Foundation Neuropathology Consortium. Schizophr Res 2004; 67: 269-275.
49. Weinberger D.R. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiat 1999; 45: 395-402.
50. Yang Z. W., Chengappa K.N., Shurin G. et al. An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia. Psychol Med 1994; 24: 449-455.
51. Zaidel D.W., Esiri M.M., Harrison P.J. Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am J Psychiat 1997; 154: 812-818.
52. Zhang Y., Taveggia C., Melendei-Vasquez C. et al Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J Neurosci 2006; 26: 12174-12185.